Refine Search
(24)
(319)
(846)
(1727)

NEW CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

  • $1,995
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – France”. The report is an essential source of information and analysis on the healthcare, regulato...

NEW CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan

  • $1,995
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Japan”. The report is an essential source of information and analysis on the healthcare, regulator...

NEW Asthma and Chronic Obstructive Pulmonary Disease: Asthma Ahead of COPD in Terms of Innovation with the Focus on Targeted Biologic Therapies for Severe Disease Phenotypes

  • $6,995
  • April 2019
Add to Basket Quick View Add to Saved List

Asthma and COPD are both highly prevalent, chronic, inflammatory diseases of the airways and lungs. The asthma market is highly saturated with relatively efficacious standard therapies and the COPD market is also highly saturated with therapies...

NEW Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes

  • $6,995
  • April 2019
Add to Basket Quick View Add to Saved List

The pain therapeutics market has been largely characterized by only incremental product innovation over the last decade, as most market segments continue to be dominated by long-established active pharmaceutical ingredients and mechanisms of ac...

NEW Biomarkers in the Central Nervous System

  • $7,995
  • April 2019
Add to Basket Quick View Add to Saved List

Biomarkers in CNS are expected to be an area that will witness strong growth in the future due to factors such as deeper understanding of the underlying disease pathology, advancements in technologies, and potential of these biomarkers that can...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2018

  • $1,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2018” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and finan...

Partnerships, Licensing, Investments and M&A Deals and Trends for January 2019 in Pharmaceuticals

  • $1,000
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for January 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) an...

Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals

  • $1,000
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) a...

Global Risk Report Quarterly Update: Q4 2018

  • $1,100
  • March 2019
Add to Basket Quick View Add to Saved List

Global Risk Report is based on GlobalData Country Risk Index (GCRI) which is a unique country risk-rating model that determines the existing and future level of country risk by assessing various qualitative and quantitative factors. The index i...

Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • March 2019
Add to Basket Quick View Add to Saved List

Multiple myeloma (MM) is a cancer of abnormal plasma cells, a type of white blood cell that is normally responsible for producing antibodies in the bone marrow. Significant improvements in progression-free survival and overall survival arrived ...

Multiple Myeloma: Epidemiology Forecast to 2027

  • $3,995
  • March 2019
Add to Basket Quick View Add to Saved List

Multiple myeloma (MM) (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C90.0) is a hematologic cancer that forms in a type of white blood cell called a plasma cell.

In 2017, ...

Osteoporosis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • March 2019
Add to Basket Quick View Add to Saved List

Osteoporosis is a disease in which the density and quality of bone are reduced over time. In a natural process known as remodeling, some of the bone cells dissolve (resorption) and new bone cells grow back (formation). For people with osteoporo...

Chronic Kidney Disease–Mineral Bone Disorders (CKD-MBD): Competitive Landscape to 2027

  • $3,495
  • March 2019
Add to Basket Quick View Add to Saved List

Chronic Kidney Disease–Mineral Bone Disorders (CKD-MBD) is one of the many complications associated with overall CKD. The systemic disorder is identified from high parathyroid hormone and disrupted K+/Ca2+ levels caused by a decreasing glomerul...

Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026

  • $3,495
  • March 2019
Add to Basket Quick View Add to Saved List

Idiopathic pulmonary fibrosis (IPF) is a progressive disease that results in the scarring of lung tissue and changes the lung’s ability to function normally. The most common signs and symptoms of idiopathic pulmonary fibrosis are dyspnea and a ...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

  • $1,995
  • March 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Germany”. The report is an essential source of information and analysis on the healthcare, regulat...

Gastrointestinal Disorders: Innovative Pipeline Offers Potential for First Approved Therapies in NASH and Celiac Disease

  • $6,995
  • March 2019
Add to Basket Quick View Add to Saved List

The burden of disease associated with gastrointestinal disorders is considerable with many of these disorders being highly prevalent. Additionally, many GI disorders are chronic in nature and are associated with significant impairments in quali...

Brexit and the Healthcare Industry Implications for Pharma – the Story so Far

  • $500
  • March 2019
Add to Basket Quick View Add to Saved List

It may take up to five years for the healthcare industry to stabilize in the event of a ‘no deal’ Brexit. This is the consensus opinion among professionals surveyed in the pharmaceutical industry, according to GlobalData, a leading data and ana...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India

  • $1,995
  • February 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India”. The report is an essential source of information and analysis on the healthcare, regulator...

Chimeric Antigen Receptor Cell Therapy

  • $7,995
  • February 2019
Add to Basket Quick View Add to Saved List

Chimeric antigen receptor (CAR) cell therapy is an immuno-oncology (IO) approach that has gained increasing momentum in the past few years, with the approval of two new therapies in 2017 (US) and 2018 (EU). Novartis’ Kymriah (tisagenlecleucel) ...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China

  • $1,995
  • January 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China”. The report is an essential source of information and analysis on the healthcare, regulator...

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease that, due to a complex interplay of environmental, immunological, and genetic factors, causes chronic inflammation and progressive deformity of the joints over time.

In 2017, the diagnose...

Rheumatoid Arthritis: Epidemiology Forecast to 2027

  • $3,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the body’s immu...

The State of the Microbiome

  • $1,495
  • January 2019
Add to Basket Quick View Add to Saved List

This report provides an assessment of how the pharmaceutical industry perceives the state of the microbiome, including the challenges associated with developing, launching, and manufacturing microbiome therapeutics as well as where opportunity ...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q3 2018

  • $1,500
  • January 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q3 2018” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and finan...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – UK

  • $1,995
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – UK”. The report is an essential source of information and analysis on the healthcare, regulatory a...

Psoriatic Arthritis: Competitive Landscape to 2026

  • $3,495
  • December 2018
Add to Basket Quick View Add to Saved List

Psoriatic arthritis is a chronic immune-mediated arthritis that typically affects the large joints, including those of the lower extremities, the distal joints of the fingers and toes, the back, and sacroiliac joints of the pelvis. Up to 30% of...

PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook – 2018 Edition

  • $4,995
  • December 2018
Add to Basket Quick View Add to Saved List

This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • December 2018
Add to Basket Quick View Add to Saved List

Psoriasis is an incurable, chronic and systemic inflammatory skin disorder with a prevalence of 2–3% worldwide. The exact causes of psoriasis is unknown, although it is believed that environmental factors, skin barrier disruptions, and immune d...

Plaque Psoriasis: Epidemiology Forecast to 2027

  • $3,995
  • December 2018
Add to Basket Quick View Add to Saved List

Plaque psoriasis is a chronic immune-mediated skin disease characterized by red, flaky patches that are itchy and sometimes painful. Psoriatic plaques are formed due to an increased production of skin cells; normally the process to make and rep...

Age-Related Macular Degeneration: Competitive Landscape to 2026

  • $3,495
  • December 2018
Add to Basket Quick View Add to Saved List

Age-Related macular degeneration (AMD) is one of the leading cause of vision loss among people ages 50 and over in the developed world, characterized by the deterioration or breakdown of the macula, a small area of the central retina needed for...

Join our mailing list
Find out first about the latest reports and offers.
Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks